fbpx

Bariatric Surgery Reduces or Eliminates Need for Blood Pressure Medication in Patients With Obesity in New 3-Year Randomized Clinical Trial

Posted on: 2nd Nov, 2020

 
GATEWAY Trial results show Patients Achieved Sustained Remission of Hypertension After Metabolic Surgery 
 
Patients with mild to moderate obesity who underwent metabolic surgery kept their blood pressure under control and required fewer or no medications compared to patients on standard medical therapy, according to a new landmark study published online in Annals of Internal Medicine. GATEWAY,
a three-year study, is the first randomized clinical trial to compare the effectiveness of surgery to medical treatment of hypertension. Early results from the GATEWAY study, first published in 2018 in the medical journal Circulation, showed similar results.
 
In the new three-year study, 35% of metabolic surgery patients achieved full remission of their hypertension without the need for continued medication, only 2% of patients on medical therapy ever did. Notably, nearly three-quarters (73%) of metabolic surgery patients were able to stop taking 30% or more of their antihypertensive medications and still maintain a blood pressure of less than 140/90 mm Hg, the study’s primary endpoint. Only 11% of those on standard medical therapy alone were able to do the same over the three-year follow-up period.
 
No patients in the medical therapy group achieved a blood pressure lower than 130/80 mm Hg, a target achieved by 31% of gastric bypass patients. In addition, patients on drug therapy experienced a modest weight gain compared to surgical patients who on average lost 27.8% of their total body weight.
 
The GATEWAY results showed that improvements and remission of high blood pressure in metabolic surgery patients are sustainable over a longer period of time while those on conventional medical treatment continue to face difficulties with both hypertension and obesity. The single center randomized study included 100 patients all of whom had obesity (BMI between 30.0 and 39.9 kg/m2) and were taking at least two blood pressure medications at maximum doses or more than two medications at moderate doses.
 
Nearly half the adults in the United States (108 million, or 45%) have hypertension and 42% have obesity, which are independent risk factors for heart disease and stroke, leading causes of death. When a patient has both conditions, the risk of cardiovascular mortality may nearly double. The Centers for Disease Control and Prevention (CDC) reports that only about 1 in 4 adults (24%) with high blood pressure have it under control.
 
Randomized clinical trials now show metabolic surgery is the most effective and durable treatment for the diseases of obesity and type 2 diabetes. GATEWAY adds to the body of high-level evidence that showing the benefits of surgery extend far beyond weight loss.
 
Metabolic surgery is today a safe, 45-minute procedure requiring 4-5 Band-aids, in the hands of Dr. Sasse. In 2019 US hospital data, the sleeve gastrectomy was safer than an appendectomy procedure. Let’s give our patients a second chance of overcoming obesity and type 2 diabetes.

Similar Recent Posts

  • How to Resolve Loose Abdominal Skin after Major Weight Loss

    • sasse-surgical-resolving-loose-abdominal-skin-after-major-weight-loss

      Major weight loss is a great thing. Studies from around the world continue to emphasize that excess body weight is bad for our health and bad for our quality of life, so losing weight is the top priority. Most people feel better, live longer, and enjoy life more after major weight loss. But that does Read More…

  • What to Expect after Your Weight-Loss Surgery Procedure

    • before-and-after-weight-loss-surgery-what-to-expect-sasse-surgical-reno

      Surprises are only nice in certain situations and usually not in situations like surgery or health care. Far better to have clear expectations for what will happen after weight-loss surgery from the moment you wake up until the one-year anniversary and beyond. Guidelines & Clarification We do our best to provide good guidelines and the Read More…

  • Newest Weight-Loss Medication is Far From a Game Changer

    • sasse-surgical-reno-weight-loss-drugs-no-game-changer

      Recently it was announced that a new weight-loss medication called Semaglutide demonstrated promising results in a trial and is moving toward FDA approval for treating obesity. It is already used at a lower dose to treat type 2 diabetes. The medication is an injectable hormone analog that is very similar to an existing weight-loss medication, Read More…

Contact Us with any Questions Regarding your Bariatric Health

It is important that you give us your accurate weight and height, so we can best assist you.

There are Two Ways to Get Started
Actual Patient
Address
Sasse Surgical Associates
75 Pringle Way
Suite 804

Reno, NV 89502
Minimally invasive weight loss surgery experts.info@sassesurgical.com(775) 829-7999
Phone
Office Hours
Monday
7:30 am - 5:00 pm
Tuesday
7:30 am - 5:00 pm
Wednesday
7:30 am - 5:00 pm
Thursday
7:30 am - 5:00 pm
Friday
7:30 am - 3:00 pm
Saturday
Closed
Sunday
Closed